Form 4: Unity Biotechnology CEO Anirvan Ghosh Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Anirvan Ghosh, CEO of Unity Biotechnology, sold 1,214 shares of common stock on June 25, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- Anirvan Ghosh, the CEO of Unity Biotechnology, sold 1,214 shares of common stock on June 25, 2024.
- The sale was executed at a price of $1.4 per share.
- The transaction was conducted under a Rule 10b5-1 trading plan.
- The purpose of the sale was to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Ghosh directly owns 76,929 shares of Unity Biotechnology.
- The reported holdings include Restricted Stock Units that vest over time from the grant date.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, not necessarily reflecting a change in the executive's outlook on the company.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is not necessarily indicative of the executive's sentiment towards the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of the stock sale transaction. |
| 06/26/2024 | Date of signature for the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.